Insider trading

Period: 120 months Stock: NTRA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

951 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

951 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

951 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

951 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
951 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
951 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

951 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
13 Sep 2024
Chapman Rowan E Director
Sold at will
$333.76K 2,614 at 127.68
24.7%
Not planned
15 Aug 2024
Sheena Jonathan Director
Sold on a plan
$1.45M 12,000 at 121.01
4.0%
Planned (10b5-1)
15 Aug 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 2×
$663.90K 5,583 at 118.91
2.7%
Planned (10b5-1)
13 Aug 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$461.55K 3,956 at 116.67
3.3%
Planned (10b5-1)
12 Aug 2024
Sheena Jonathan Director
Sold on a plan 4×
$307.31K 2,700 at 113.82
0.9%
Planned (10b5-1)
31 Jul 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$185.95K 1,866 at 99.65
2.5%
Planned (10b5-1)
29 Jul 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$419.70K 4,084 at 102.77
1.9%
Planned (10b5-1)
29 Jul 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$127.22K 1,238 at 102.77
1.6%
Planned (10b5-1)
29 Jul 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$122.91K 1,196 at 102.77
1.1%
Planned (10b5-1)
29 Jul 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$108.62K 1,057 at 102.77
0.5%
Planned (10b5-1)
29 Jul 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$95.47K 929 at 102.77
0.8%
Planned (10b5-1)
26 Jul 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$76.74K 751 at 102.18
1.0%
Planned (10b5-1)
25 Jul 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$72.65K 690 at 105.29
0.9%
Planned (10b5-1)
24 Jul 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$96.88K 918 at 105.53
1.2%
Planned (10b5-1)
23 Jul 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$53.59K 499 at 107.40
0.6%
Planned (10b5-1)
22 Jul 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$277.41K 2,638 at 105.16
1.2%
Planned (10b5-1)
22 Jul 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$111.36K 1,059 at 105.16
1.3%
Planned (10b5-1)
22 Jul 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$85.70K 815 at 105.16
0.4%
Planned (10b5-1)
22 Jul 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$57.73K 549 at 105.16
0.5%
Planned (10b5-1)
22 Jul 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$57.73K 549 at 105.16
0.5%
Planned (10b5-1)
15 Jul 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 2×
$613.67K 5,496 at 111.66
2.6%
Planned (10b5-1)
1 Jul 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 3×
$4.05M 37,500 at 108.10
14.9%
Planned (10b5-1)
1 Jul 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$539.99K 4,983 at 108.37
6.2%
Planned (10b5-1)
1 Jul 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$295.08K 2,723 at 108.37
1.3%
Planned (10b5-1)
1 Jul 2024
Sheena Jonathan Director
Sold on a plan 2×
$293.94K 2,700 at 108.87
0.9%
Planned (10b5-1)
18 Jun 2024
Sheena Jonathan Director
Sold on a plan
$296.08K 2,700 at 109.66
0.9%
Planned (10b5-1)
17 Jun 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 3×
$681.37K 6,105 at 111.61
2.8%
Planned (10b5-1)
30 May 2024
Sold at will
$220.33K 2,000 at 110.17
9.7%
Not planned
28 May 2024
Chapman Rowan E Director
Sold at will
$529.73K 4,856 at 109.09
49.2%
Not planned
28 May 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$181.10K 1,647 at 109.96
1.4%
Planned (10b5-1)
28 May 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$158.12K 1,438 at 109.96
1.3%
Planned (10b5-1)
23 May 2024
Sheena Jonathan Director · indirect
Sold on a plan 4×
$108.30K 1,000 at 108.30
1.4%
Planned (10b5-1)
15 May 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 2×
$725.91K 6,779 at 107.08
3.0%
Planned (10b5-1)
10 May 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 4×
$3.14M 30,000 at 104.59
12.8%
Planned (10b5-1)
10 May 2024
Sheena Jonathan Director
Sold on a plan 5×
$283.79K 2,700 at 105.11
0.8%
Planned (10b5-1)
1 May 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 4×
$175.34K 1,866 at 93.97
2.7%
Planned (10b5-1)
29 Apr 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$380.38K 4,084 at 93.14
1.8%
Planned (10b5-1)
29 Apr 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$115.31K 1,238 at 93.14
1.8%
Planned (10b5-1)
29 Apr 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$111.39K 1,196 at 93.14
1.0%
Planned (10b5-1)
29 Apr 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$98.45K 1,057 at 93.14
0.5%
Planned (10b5-1)
29 Apr 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$86.53K 929 at 93.14
0.8%
Planned (10b5-1)
26 Apr 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$69.09K 751 at 92.00
1.1%
Planned (10b5-1)
25 Apr 2024
Sheena Jonathan Director · indirect
Sold on a plan 2×
$89.55K 1,000 at 89.55
1.4%
Planned (10b5-1)
25 Apr 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$63.13K 705 at 89.55
1.0%
Planned (10b5-1)
24 Apr 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$87.14K 937 at 93.00
1.3%
Planned (10b5-1)
23 Apr 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$233.20K 2,552 at 91.38
1.1%
Planned (10b5-1)
23 Apr 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$139.17K 1,523 at 91.38
2.0%
Planned (10b5-1)
23 Apr 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$71.92K 787 at 91.38
0.4%
Planned (10b5-1)
23 Apr 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$48.52K 531 at 91.38
0.5%
Planned (10b5-1)
23 Apr 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$47.70K 522 at 91.38
0.5%
Planned (10b5-1)
Showing 351–400 of 951. ← Newer Page 8 of 20 Older →